D’Agosto, Sabrina
Pezzini, Francesco
Veghini, Lisa
Delfino, Pietro
Fiorini, Claudia
Temgue Tane, Gael D.
Del Curatolo, Anais
Vicentini, Caterina
Ferrari, Giorgia
Pasini, Davide http://orcid.org/0000-0002-8270-7143
Andreani, Silvia
Lupo, Francesca
Fiorini, Elena
Lorenzon, Giulia
Lawlor, Rita T.
Rusev, Borislav
Malinova, Antonia
Luchini, Claudio http://orcid.org/0000-0003-4901-4908
Milella, Michele
Sereni, Elisabetta
Pea, Antonio
Bassi, Claudio
Bailey, Peter
Scarpa, Aldo http://orcid.org/0000-0003-1678-739X
Bria, Emilio
Corbo, Vincenzo http://orcid.org/0000-0002-6340-8009
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (861196)
Associazione Italiana per la Ricerca sul Cancro (18178, 24043, 19404, 20872, 25286, 12182, IG20583)
Fondazione Umberto Veronesi
Article History
Received: 8 February 2022
Revised: 28 July 2022
Accepted: 1 August 2022
First Online: 13 August 2022
Competing interests
: EB received speakers’ and travels’ fee from MSD, Astra-Zeneca, Pfizer, Eli-Lilly, BMS, Novartis and Roche. EB received institutional research grants from Astra-Zeneca, Roche. The other authors declare no competing interests.